Thyroglobulin (anti-TG) and/or thyroid peroxidase (anti-TPO) autoantibodies are associated with higher rates of poor gestational outcomes.
OBJECTIVE:
To demonstrate the impact of anti-TPO and anti-TG autoantibodies on the gestational outcomes of euthyroid pregnant women with a history of poor gestational outcome and thyroid gland disorders.
METHODS:
This retrospective study included totally 75 euthyroid pregnant, 30 of women with high thyroid autoantibodies (Anti-TPO/Thyroglobulin-positive group) and 45 of them without autoantibodies (control group).
RESULTS:
We could not demonstrate significant differences between two groups in terms of risk factors/co-morbidities, obstetric complications, gestational outcomes, and birth data ( 0.05). However, enhanced miscarriage rates were observed among the Anti-TPO/Thyroglobulin-positive and control groups without significance (36.7% and 17.8% respectively, 0.116). High neonatal intensive care unit (NICU) admission rates were found for control and Anti-TPO/Thyroglobulin-positive groups (16.2% and 21.1%, respectively) ( 0.720). Clinically, we compared the two groups in terms of the existence and the types of goiter (diffuse and nodular), and demonstrated that nodular goiter was statistically more frequent in the control group (40.0% vs. 8.7%, 0.015). Alongside, relatively high hereditary thrombophilia and type-2 diabetes mellitus rates were found in the Anti-TPO/Thyroglobulin-positive group (20.0% and 20.0%).
CONCLUSION:
Thyroid autoantibody positivity is likely a risk factor for early pregnancy loss and NICU admission.
AlaviA.AdabiK.NekuieS.JahromiE.K.SolatiM.SobhaniA.KarmostajiH.JahanlouA.S., Thyroid dysfunction and autoantibodies association with hypertensive disorders during pregnancy, Journal of Pregnancy2012 (2012), 742695. doi: 10.1155/2012/742695.
2.
ErolS.A.CaglarA.T.Engin UstunY. and Ozgu ErdincA.S., Evaluation of perinatal and neonatal outcomes in pregnant women with thyroid autoantibody positivity (Anti-thyroglobulin and Anti-thyroid Peroxidase) due to thyroiditis, SN Compr Clin Med4 (2022), 69. doi: 10.1007/s42399-022-01151-y.
3.
LiC.ZhouJ.HuangZ.PanX.LeungW.ChenL.ZhangY.WangL.SimaY.GoberH.J.ZhangN.QiuX.LiL.GuanL. and WangL., The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy, Disease Markers2020 (2020), 8871951. doi: 10.1155/2020/8871951.
4.
Dhillon-SmithR.K. and CoomarasamyA., TPO antibody positivity and adverse pregnancy outcomes, Best Pract Res Clin Endocrinol Metab34 (2020), 101433. doi: 10.1016/J.BEEM.2020101433.
5.
HeX.WangP.WangZ.HeX.XuD. and WangB., Thyroid antibodies and risk of preterm delivery: A meta-analysis of prospective cohort studies, Eur J Endocrinol167 (2012), 455–64. doi: 10.1530/EJE-12-0379.
6.
MumusogluS.BeksacM.S.EkizA.OzdemirP. and HascelikG., Does the presence of autoantibodies without autoimmune diseases and hereditary thrombophilia have an effect on recurrent pregnancy loss? J Matern Fetal Neonatal Med29 (2016), 2352–7. doi: 10.3109/14767058.2015.1085964.
7.
WakitaY.NagasakiT.Nagata YY.ImanishiY.YamadaS.YodaK.EmotoM.IshimuraE. and InabaM., Thyroid heterogeneity, as indicated by the CV of ultrasonographic intensities, correlates with anti-thyroid peroxidase antibodies in euthyroid Hashimoto’s thyroiditis, Thyroid Res6 (2013), 5. doi: 10.1186/1756-6614-6-5.
8.
FröhlichE. and WahlR., Thyroid autoimmunity: Role of Anti-thyroid antibodies in thyroid and extra-thyroidal diseases, Front Immunol8 (2017), 521. doi: 10.3389/fimmu.2017.00521.
9.
ZaletelK. and GaberscekS., Hashimoto’s thyroiditis: from genes to the disease, Curr Genomics12 (2011), 576–88. doi: 10.2174/138920211798120763.
10.
JoK. and LimD.J., Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer, Korean J Intern Med33 (2018), 1050–57. doi: 10.3904/kjim.2018289.
11.
McLachlanS.M. and RapoportB., Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid14 (2004), 510–20. doi: 10.1089/1050725041517057.
12.
BalucanF.S.MorshedS.A. and DaviesT.F., Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance, J Thyroid Res2013 (2013), 182472. doi: 10.1155/2013/182472.
13.
TunbridgeW.M.EveredD.C.HallR.AppletonD.BrewisM.ClarkF.EvansJ.G.YoungE.BirdT. and SmithP.A., The spectrum of thyroid disease in a community: the Whickham survey, Clin Endocrinol (Oxf)7 (1977), 481–93. doi: 10.1111/j1365-2265.1977.tb01340.x.
14.
BeksaçM.S.AydinE. and TurğalM.K.E., An Obstetrics Index for the Assessment of Risk Levels of “High Risk Pregnancy” Groups, Gynecol Obstet Reprod Med21 (2015), 10–3.
15.
GyamfiC.WapnerR.J. and D’AltonM.E., Thyroid dysfunction in pregnancy: the basic science and clinical evidence surrounding the controversy in management, Obstet Gynecol113 (2009), 702–7. doi: 10.1097/AOG.0b013e3181996fe5.
16.
ThangaratinamS.TanA.KnoxE.KilbyM.D.FranklynJ. and CoomarasamyA., Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence, BMJ342 (2011), d2616. doi: 10.1136/bmj.d2616.
17.
RushworthF.H.BackosM.RaiR.ChilcottI.T.BaxterN. and ReganL., Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies, Hum Reprod15 (2000), 1637–9. doi: 10.1093/humrep/15.7.1637.
18.
ZhongY.P.YingY.WuH.T.ZhouC.Q.XuY.W.WangQ.LiJ.ShenX.T. and LiJ., Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer, Int J Med Sci9 (2012), 121–5. doi: 10.7150/ijms.3467.
19.
SchmidtM.VoellM.RahlffI.DietleinM.KobeC.FaustM. and SchichaH., Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) treated with levothyroxine, Thyroid18 (2018), 755–60. doi: 10.1089/thy.2008.0008.
20.
MeenaA. and NagarP., Pregnancy outcome in euthyroid women with Anti-thyroid peroxidase antibodies, J Obstet Gynaecol India66 (2016), 160–5. doi: 10.1007/s13224-014-0657-6.
21.
TanacanA.BeksacM.S.OrgulG.DuruS.SenerB. and KaraagaogluE., Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes, Hum Antibodies27 (2019), 135–41. doi: 10.3233/HAB-180359.
22.
ÜnalC.FadilogluE. and BeksacM.S., Pregnancy outcomes of the patients with anti-smooth muscle antibody positivity, Hum Antibodies27 (2019), 167–70. doi: 10.3233/HAB-190365.
23.
FadilogluE.UnalC. and BeksacM.S., Management and the pregnancy outcomes of patients positive for anti-parietal cell antibody, Hum Antibodies27 (2019), 111–6. doi: 10.3233/HAB-180355.
24.
BeksacM.S.TanacanA.OztenG. and CakarA.N., Low-dose low-molecular-weight heparin prophylaxis against obstetrical complications in pregnancies with metabolic and immunological disorder-associated placental inflammation, J Matern Fetal Neonatal Med35 (2022), 1546–53. doi: 10.1080/14767058.20201760834.
25.
BeksacK.TurgalM.BasaranD.AranO. and BeksacM.S., Vaginoperineal fistula as a complication of perianal surgery in a patient with Sjögren’s Syndrome: A case report, Case Rep Rheumatol2014 (2014), 1–3. doi: 10.1155/2014/359605.
26.
ÖrgülG.SoyakB.AydınE.TanaçanA.ÇağanM.BeksaçM.S., 22 Haftayı Geçemeyen Gebelikler, Jinekoloji – Obstet ve Neonatoloji Tıp Derg14 (2017), 66–9.
27.
TurgalM.GumrukF.KaraagaogluE. and BeksacM.S., Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome, Geburtshilfe Frauenheilkd78 (2018), 871–8. doi: 10.1055/a-0664-8237.
28.
GurbuzR.H.AtillaP.OrgulG.TanacanA.DolgunA.CakarA.N. and BeksacM.S., Impaired placentation and early pregnancy loss in patients with MTHFR polymorphisms and Type-1 Diabetes mellitus, Fetal Pediatr Pathol38 (2019), 376–86. doi: 10.1080/15513815.2019.1600623.
29.
CaganM.OkuducuU.DonmezH.G. and BeksacM.S., Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and Methylenetetrahydrofolate reductase polymorphisms, Hum Antibodies30 (2022), 59–65. doi: 10.3233/HAB-211517.
30.
AngumF.KhanT.KalerJ.SiddiquiL. and HussainA., The prevalence of autoimmune disorders in women: a narrative review, Cureus12 (2020), e8094. doi: 10.7759/cureus.8094.
31.
SazciA.ErgulE.KayaG. and KaraI., Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey, Cell Biochem Funct23 (2005), 51–4. doi: 10.1002/cbf.1132.
32.
GumrukF.OrgulG.DoganO.A.TanacanA.KaraagaogluE. and sBeksacM.S., The prevalence of homozygous MTHFR polymorphism(s) in a Turkish university hospital population that necessitated MTHFR polymorphism investigation, Electron J Gen Med15 (2018), em57.
33.
De StefanoV.RossiE.ZaT. and LeoneG., Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia, Semin Thromb Hemost32 (2006), 767–80. doi: 10.1055/s-2006-955459.
34.
KhanM.A.B.HashimM.J.KingJ.K.GovenderR.D.MustafaH. and KaabiJ.A., Epidemiology of Type 2 Diabetes – global burden of disease and forecasted trend, J Epidemiol Glob Health10 (2020), 107–11. doi: 10.2991/jegh.k.191028001.
35.
GebremichaelG.DemenaM.EgataG. and GebremichaelB., Prevalence of goiter and associated factors among adolescents in Gazgibla District, Northeast Ethiopia, Glob Adv Heal Med9 (2020), 2164956120923624. doi: 10.1177/2164956120923624.
36.
GlinoerD. and LemoneM., Goiter and pregnancy: a new insight into an old problem, Thyroid2 (1992), 68–70. doi: 10.1089/thy.1992.2.65.
37.
JasimS. and GharibH., Multinodular Goiter, in: Thyroid nodules Contemp Endocrinol book series, 2000, pp. 135–52. doi: 10.1007/978-3-319-59474-3_10.
38.
KaliszewskiK.Strutyńska-KarpińskaM.Zubkiewicz-KucharskaA.WojtczakB.DomosławskiP.BalcerzakW.ŁukieńczukT. and ForkasiewiczZ., Should the prevalence of incidental thyroid cancer determine the extent of surgery in multinodular goiter? PLoS One11 (2016), e0168654. doi: 10.1371/journal.pone.0168654.
39.
UyarO.CetinB.AkselB.DoganL.BeksacK.AkgulG.G.BerberogluU. and GulcelikM.A., Malignancy in solitary thyroid nodules: evaluation of risk factors, Oncol Res Treat, 40 (2017), 360–3. doi: 10.1159/000464409.
40.
BeksaçK.AktozF.ÖrgülG.ÇelikH.T.Özgü-ErdinçA.S. and BeksaçM.S., Pregnancy in papillary thyroid cancer survivors, J Turkish Ger Gynecol Assoc19 (2018), 94–7. doi: 10.4274/jtgga.2017.0057.
41.
NeyziO.GünözH. and CelenkA.B.R., Birth weight in Turkish infants, Hum Biol58 (1986), 367–78.
42.
KimY.Ganduglia-CazabanC.ChanW.LeeM.J. and GoodmanD.C., Trends in neonatal intensive care unit admissions by race/ethnicity in the United States, 2008–2018, Sci Rep11 (2021), 23795. doi: 10.1038/s41598-021-03183-1.
43.
HarrisonW. and GoodmanD., Epidemiologic trends in neonatal intensive care, 2007–2012, JAMA Pediatr169 (2015), 855–62. doi: 10.1001/jamapediatrics.2015.1305.
